Revenue: The sum of all revenue fields included for a company's operating activities.
Cytek Biosciences, Inc. (CTKB) had Revenue of $48.14M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$48.14M |
$-12.16M |
|
$19.80M |
|
$28.34M |
|
$59.54M |
|
$-11.40M |
|
$-0.24M |
|
$-11.64M |
|
$-11.64M |
|
$-12.16M |
|
$-12.16M |
|
$-12.16M |
|
$-12.16M |
|
$-11.40M |
|
$-8.41M |
|
129.46M |
|
129.46M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$377.93M |
|
$20.80M |
|
$69.00M |
|
$446.93M |
|
$84.33M |
|
$0.25M |
|
$40.65M |
|
$124.98M |
|
$321.95M |
|
$290.40M |
|
$321.95M |
|
129.98M |
|
| Cash Flow Statement Financials | |
$-1.37M |
|
$-20.06M |
|
$3.17M |
|
$90.85M |
|
$73.85M |
|
$-17.01M |
|
$10.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.48 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
58.87% |
|
-23.68% |
|
-23.68% |
|
-- |
|
-24.19% |
|
-25.26% |
|
$-5.74M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.38 |
|
0.97 |
|
92.91 |
|
-3.78% |
|
-4.19% |
|
-2.72% |
|
-3.77% |
|
$2.48 |
|
$-0.04 |
|
$-0.01 |
|